期刊文献+

细胞因子在老年性痴呆早期诊断中的应用研究 被引量:1

Association of pro-inflammatory cytokine levels with cognitive function in elderly patients with dementia
下载PDF
导出
摘要 目的 研究老年性痴呆(AD)患者外周血中细胞因子浓度与认知功能的关系.方法 搜集认知功能正常者,轻度认知障碍(MCI)以及AD 患者,评估患者的认知功能,采集患者静脉血,利用酶联免疫吸附试验检测细胞因子(IL-β、IL-6 和IL-4、IL-10、IL-13).结果 IL-1茁、IL-6、IL-10在3组之间差异有统计学意义(P<0.05),其中AD、MCI以及正常老年人差异具有统计学意义.结论 MCI患者作为AD 的临床前状态,认知功能的损害不同于AD,免疫状态也发生改变. Objective To investigate the association of pro-inflammatory cytokines with cognitive function in elderly patients with dementia. Methods The cognitive function was assessed in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD), subjects with normal cognitive function served as controls. Blood samples were collected from above subjects and serum IL-α, IL-β, IL-6, TNF-α levels were measured with enzyme-linked immunosorbent assay. Results There were significant differences in serum IL-1β, IL-6, IL-10 levels among three groups. The pro-inflammatory cytokine levels in AD and MCI patients were significantly higher than those in subjects with normal cognitive functions Conclusion MCI patients as a preclinical condition of AD also demonstrate changes of immune functions.
出处 《浙江医学》 CAS 2012年第3期159-161,172,共4页 Zhejiang Medical Journal
基金 浙江省医药卫生科技计划项目(2006A013) 浙江省老年医学重点学科群(2007zj008) 浙江省自然科学基金(Y2091289)
关键词 轻度认知障碍 阿尔茨海默病 细胞因子 Mild cognitive impairment Alzheimer disease Cytokines
  • 相关文献

参考文献10

  • 1RobertMC.The Role of the Immune Systemin Alzheimer's Disease[J].Focus,2009,7:28-35.
  • 2中国精神障碍分类与诊断标准第3版(精神障碍分类).中华精神科杂志,2001,34(3):184-184.
  • 3张明园.精神科评定量表手册[M].长沙:湖南科学技术出版社,2003.39.
  • 4Morris J C.The Clinical Dementia Rating (CDR):Current version and scoring rules[J].Neurology,1993,43:2412.
  • 5McKhann G,Drachman D,Folstein M,et al.Clinical diagnosis of Alzheimer's Disease:report of the NINCDS -ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease[J].Neurology,1984,34:939-944.
  • 6Grundman M,Petersen R C,Ferris S H,et al.Alzheimer's disease Cooperative Study.Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials[J].Arch Neurol,2004,61:59-66.
  • 7吴万振,于恩彦.轻度认知障碍概念和神经心理学研究进展[J].神经疾病与精神卫生,2007,7(4):311-315. 被引量:7
  • 8Heneka M T,O'Banion M K,Terwel D,et al.Neuroinflammatory processes in Alzheimer's disease[J].J Neural Transm,2010,117:919-947.
  • 9Sala G,Galimberti G,Canevari C,et al.Peripheral cytokine release in Alzheimer patients:correlation with disease severity[J].Neurobiol Aging,2003,24(7):909-914.
  • 10Mrak R E,Griffinbc W S.The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzhei-mer's disease[J].Neurobiol Aging,2001,22(6):915-922.

二级参考文献17

  • 1赵永波,周晓琳.轻度认知障碍[J].神经疾病与精神卫生,2004,4(5):389-392. 被引量:14
  • 2向莉,张巧俊,甄长安.事件相关电位和脑电图在痴呆早期诊断中的意义[J].神经疾病与精神卫生,2007,7(2):126-128. 被引量:3
  • 3Chertkow H,Bergman H,Schipper HM,et al.Assessment of suspected dementia[J].Can J Neurol Sci,2001,28(suppl 1):28-41.
  • 4Davis HS,Rockwood K.Conceptualization of mild cognitive impairment:a review[J].Int J Geriatr Psychiatry,2004,19(4):313-319.
  • 5Collie A,Maruf P.The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment[J].Neurosci Biobehav Rev,2000,24(3):365-374.
  • 6Ritchie K,Touchon J.Mild cognitive impairment:conceptual basis and current nosological status[J].Lancet,2000,355(9199):225-228.
  • 7DeCarli C.Mild cognitive impairment:prevalence,prognosis,aetiology,and treatment[J].Lancet Neurol,2003,2(1):15-21.
  • 8Luis CA,Loewenstein DA,Acevedo A,et al.Mild cognitive impairment:Directions for future research[J].Neurology,2003,61:438-444.
  • 9Petersen RC,Doody R,Kurz A,et al.Current concepts in mild cognitive impairment[J].Arch Neurol,2001,58:1 985-1 992.
  • 10Panza F,DIntrono A,Colacicco AM,et al.Current epidemiology of mild cognitive impairment and other predementia syndromes[J].Am J Geriatr Psychiatry,2005,13(8):633-644.

共引文献452

同被引文献10

  • 1吴万振,于恩彦.轻度认知障碍概念和神经心理学研究进展[J].神经疾病与精神卫生,2007,7(4):311-315. 被引量:7
  • 2Robert MC. The role of the immune system inAlzheimer's disease. Focus,2009,7:28-35.
  • 3Grundman M,Petersen RC,Ferris SH,et al.Alzheimer's disease cooperative study. Mild cognitiveimpairment can be distinguished from Alzheimerdisease and normal aging for clinical trials. ArchNeurol,2004,61 :59-66.
  • 4Morris JC. The clinical dementia rating (CDR):current version and scoring rules. Neurology,1993,43:2412.
  • 5McKhann G,Drachman D,Folstein M,et al.Clinical diagnosis of Alzheime/s disease:report ofthe NINCDS-ADRD A Work Group under theauspices of department of health and Human ServiceTask Force on Alzheimer's Disease. Neurology,1984,34;939-944.
  • 6Sala G,Galimberti G,Canevari C,et al. Peripheralcytokine release in Alzheimer patients :correlationwith disease severity. Neurobiol Aging,2003,24 :909-914.
  • 7Richartz E,Stransky E,Batra A,et al. Decline ofimmune responsiveness:pathogenetic factor inAlzheimer' s disease? J Psychiatr Res,2005,39:535-543.
  • 8Lombardi VR,Garcia M,Rey L,et al.Characterization of cytokine production,screening oflymphocyte subset patterns and in vitro apoptosis inhealthy and Alzheimer7 s disease (AD)individuals. JNeuroimmunol,1999 ,97 :163-171.
  • 9Serini S,Bizzarro A,Piccioni E,et al. EPA andDHA differentially affect in vitro inflammatorycytokine release by peripheral blood mononuclear cellsfrom Alzheimer' s patients. Curr Alzheimer Res,2012,9:913-923.
  • 10高晶.老年期痴呆的及时诊断[J].中华老年医学杂志,2012,31(1):18-20. 被引量:6

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部